Cannabis effects on inflammation pathways

CB2 Receptor Signaling and Inflammation

CB2 receptors are found primarily on immune cells, including macrophages and microglia, where they help regulate inflammation and immune responses. When activated by cannabinoids such as THC or the naturally occurring 2-AG, CB2 receptors influence intracellular signaling pathways, including cAMP/PKA, MAPK, and NF-κB. These effects may reduce the production of pro-inflammatory cytokines such as TNF-α, IL-1β, and IL-6, helping limit excessive inflammation and inflammatory pain. Through these mechanisms, CB2 activation may contribute to reduced neuroinflammation, improved immune regulation, and protection against inflammation-related tissue damage.

Cannabinoid and Adensosine Pathways and Inflammation:

CBD may help regulate inflammation by influencing the adenylyl cyclase (AC)–cAMP signaling pathway through cannabinoid (CB1 and CB2) and adenosine (A1 and A2A) receptors. By modulating these receptors and increasing extracellular adenosine, CBD can alter intracellular cAMP levels and downstream PKA–CREB signaling, which helps regulate inflammatory gene expression. These interactions may reduce NF-κB activity and the production of pro-inflammatory cytokines such as TNF-α, IL-6, and IL-1β. Potential therapeutic effects include reduced inflammation, neuroinflammation, and pain signaling, although these outcomes depend on the specific receptors, cell types, and physiological conditions involved.

How CBD Modulates Inflammation Through PPARγ and NF-κB Signaling

CBD (cannabidiol) is a fat-soluble compound that can cross cell membranes and influence intracellular pathways involved in inflammation. Once inside the cell, CBD may interact with fatty acid-binding proteins (FABPs) and activate PPARγ, a nuclear receptor that regulates gene expression, potentially increasing anti-inflammatory mediators such as IL-10 and adiponectin. CBD may also inhibit the NF-κB inflammatory pathway by reducing activation of the IKK complex, helping preserve IκB and limiting NF-κB movement into the nucleus. This may decrease the production of pro-inflammatory cytokines, including TNF-α, IL-6, and IL-1β. Together, these pathways may help regulate immune responses, reduce neuroinflammation, and support cellular health and tissue protection. Most of these mechanisms have been demonstrated in laboratory and preclinical studies, with their clinical significance still under investigation.

CBD Regulation of Immune Cell Migration and Tissue Repair

CBD may help regulate inflammation by influencing cellular signaling pathways involved in immune cell movement and tissue repair. Through interactions with CB2, PPARγ, and TRPV1, CBD may modulate inflammatory pathways such as NF-κB, PI3K/Akt, and MAPK, potentially reducing excessive immune cell migration toward inflamed tissues. These effects may help limit inflammatory cell infiltration, promote resolution of inflammation, and support balanced tissue repair and healing. Most evidence for these mechanisms comes from laboratory and preclinical studies, and their clinical significance continues to be investigated.

CBD Regulation of Immune Cell Migration and Tissue Repair

CBD may help regulate inflammation by influencing cellular signaling pathways involved in immune cell movement and tissue repair. Through interactions with CB2, PPARγ, and TRPV1, CBD may modulate inflammatory pathways such as NF-κB, PI3K/Akt, and MAPK, potentially reducing excessive immune cell migration toward inflamed tissues. These effects may help limit inflammatory cell infiltration, promote resolution of inflammation, and support balanced tissue repair and healing. Most evidence for these mechanisms comes from laboratory and preclinical studies, and their clinical significance continues to be investigated.